Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia

Steven E. Lipshultz(Jacobs Institute), Lewis B. Silverman(Columbia University Irving Medical Center), Vivian I. Franco(University of Miami), Jeffery L. Kutok(NKT Therapeutics (United States)), Luis A. Clavell(San Juan City Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Uma H. Athale(McMaster University), Mark D. Fleming(Boston Children's Hospital), Jacqueline Henkel(University of Miami), Barbara L. Asselin(University of Rochester Medical Center), Stuart R. Lipsitz(Brigham and Women's Hospital), Bruno Michon(Centre hospitalier universitaire de Québec), Stephen E. Sallan, Caroline Laverdière(Centre Hospitalier Universitaire Sainte-Justine), Kara M. Kelly(Roswell Park Comprehensive Cancer Center), Kristen E. Stevenson(Dana-Farber Cancer Institute), Steven D. Colan(Boston Children's Hospital), Tracie L. Miller(University of Missouri–Kansas City), Donna Neuberg(Otsuka (Japan))
Cancer
July 16, 2013
Cited by 160


Related Papers